# OnCo record endometrial-molecular-classes (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/endometrial-molecular-classes/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "endometrial-molecular-classes" ;
  schema:name "Endometrial cancer molecular classes (POLEmut, MMRd, p53abn, NSMP)"@en ;
  schema:alternateName "ProMisE"@en, "ProMisE classifier"@en, "molecular classification of endometrial cancer"@en, "TCGA endometrial subtypes"@en, "WHO 2020 endometrial molecular classification"@en, "endometrial molecular class"@en, "molecular class"@en ;
  schema:description "Four groups defined by a few tests that predict outcome better than the microscope: POLE-mutated (excellent), mismatch-repair deficient, p53-abnormal (worst), and 'no specific profile'."@en ;
  schema:url <https://onco.cc/terms/endometrial-molecular-classes/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Endometrial_cancer> ;
  schema:citation <https://www.nature.com/articles/nature12113> ;
  onco:cancers <https://onco.cc/cancers/endometrial/> ;
  onco:targets <https://onco.cc/targets/tp53/>, <https://onco.cc/targets/her2/> ;
  onco:terms <https://onco.cc/terms/msi/> ;
  onco:trials <https://onco.cc/trials/portec-3/> .